AstraZeneca plc, BP plc and Unilever plc are Brexit dividend WINNERS

AstraZeneca plc (LON: AZN), BP plc (LON: BP) and Unilever plc (LON: ULVR) are proving a handy foxhole amid a barrage of Brexit bad news, says Harvey Jones.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Not every company stock collapsed in the aftermath of the shock Brexit referendum result, canny investors spotted opportunities as well as threats to their portfolio. As the pound collapsed, income seekers realised that companies with strong overseas earnings should prove more rewarding. Here are three stocks that are likely to be Brexit dividend winners.

Astra shines

Pharmaceuticals giant AstraZeneca (LSE: AZN) ended Friday 3.41% higher and is up 10.36% across the last turbulent week. Over the same period, sterling has fallen from around $1.46 to $1.33, a drop of around 9%. That is far from a coincidence. AstraZeneca generate more than 90% of its profits overseas but has a large cost base in the UK, which will be less of a burden as its overseas earnings rise relative to the pound.

AstraZeneca converts its dividends into pence on the day results are announced – twice a year in March and September – and although we don’t know whether the dollar will remain strong against sterling over the longer term, that’s certainly the way to bet right now. The company suffered during recent sterling strength, with Q1 results showing revenue up 5% to $6,115m, but just 1% at actual exchange rates. That now looks set to reverse. Trading at 13.3 times earnings it isn’t overpriced, while the yield is healthy at 4.9%. The big question is whether chief executive Pascal Soriot can replenish AstraZeneca’s drugs pipeline, but for now the dollar pipeline will be flowing.

Brexit petroleum

Friday’s result may have divided the nation but it united investors in pursuit of oil major BP (LSE: BP), whose share price rose 1.73% on the day and now stands nearly 6% higher than it did a week ago. In January, chief executive Bob Dudley warned that investment in the UK energy sector could fall if Britain voted to leave the EU. But the company put on a brave face after the result, publicly stating that “we do not currently expect it to have a significant impact on BP’s business or investments in the UK and continental Europe, nor on the location of our headquarters or our staff“. Investors are taking that at face value today.

The uncertainty has set back the oil price recovery, with Brent crude falling from over $50 to around $47 a barrel, but markets are calculating that this is only temporary. Sterling weakness is likely to last much longer and with oil priced in dollars BP’s revenues will be the beneficiary. As will income seekers, given that BP declares its dividend in dollars, and its current yield of 7.1% has just got even juicier.

Uni winner

Household goods giant Unilever (LSE: ULVR) is another instant Brexit winner rising 3.11% on the day and trading 6.72% higher over the week. Almost 60% of its revenues come from emerging markets, with dollar and euro earnings on top, which is good news when sterling is plunging against a basket of global currencies. 

Unilever reports in euros and UK investors have already benefitted from pre-referendum uncertainty: Unilever recently raised its Q1 dividend by 6% to EUR0.3201 per share, which equated to 17% in sterling terms. We can expect more of that, unless the euro comes under greater pressure as Brexit contagion spreads.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended AstraZeneca and BP. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

£3,000 in savings? Here’s how I’d use that to start earning a monthly passive income

Our writer digs into the details of how spending a few thousand pounds on dividend shares now could help him…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »